
    
      SarcBOP is initiated at the National Center for Tumor Diseases (NCT) Heidelberg. The
      infrastructure is designed universally to enable extension to further centers.

      All patients with newly diagnosed or preexistent STBS at participating centers are intended
      to be registered within SarcBOP. Prior to inclusion, patients have to give their written
      informed consent.

      The following data will be collected and stored:

        -  Demographics

        -  Comorbidities

        -  Clinical characteristics at diagnosis, relapse and progression

        -  Treatments including DRG and OPS data

        -  Longitudinal disease assessments

        -  Clinical outcome

        -  Genomic, transcriptomic, epigenomic and proteomic data

        -  Quality-of-life assessments Furthermore, biological samples will be collected and
           processed by the Sample Processing Laboratory of the Heidelberg Center for Personalized
           Oncology and the NCT Biobank.
    
  